1 min read
Veranex’s Model Assesses EXENT® GAM Assay* Savings in Myeloma Patient Monitoring
The investigational model considered the use of the EXENT® GAM Assay from the Binding Site, part of Thermo Fisher Scientific. This is a mass...
Commercial Strategy & Market Access
2 min read
The New Normal for Market Access in China: Volume Based Procurement
Our previous update1, Analysis of China’s First National Tender on Coronary Stents, discussed the first national-level centralized tender for a...